ATMPs

For families affected by a rare and ultra-rare genetic disorder, the distance between a promising laboratory result and an accessible treatment can feel impossibly large. Developing a gene therapy requires much more than identifying ...

How does a breakthrough gene therapy begin? What does it take to turn a scientific idea into a treatment that can reach a patient? In this interview, Duško Lainšček, researcher at the Institute of Chemistry ...

On 12 June 2026, representatives of the National Institute of Chemistry and CTGCT visited Gimnazija Jesenice, where they presented modern biological medicines and the development of gene and cell therapies to third-year students.

The CTGCT was represented at the GMP Symposium 2026, held in Tuheljske Toplice, where leading experts gathered to exchange knowledge and practical experiences in GMP environments. As part of the scientific program, our head Dr. ...

In our latest edition of the CTGCT Science Talks webinar series we had Dr. Thomas Fox, a clinician-scientist whose work bridges the gap between the clinical-laboratory interface working across Harvard Medical School and the ...

Last week 3 of our colleagues (Tjaša, Mojca and Tina) attended the UCL Advanced Therapies Symposium 2026 in London, an event dedicated to recent developments in cell and gene therapies and to strengthening links ...

On Friday, February 27, 2026, part of our team joined experts, decision-makers, and patient advocates at the 12th National Rare Disease Day Conference held at the Congress Center Brdo pri Kranju. The event, organized by ...

Imagine being able to open the "instruction manual" of a human cell and fix a single typo that causes a life-threatening disease. This is no longer science fiction; it is the reality of base ...

On the 12th of January 2026, Claudia Beltran Mestre, from the Berlin Center for Advanced Therapies at Charité Universitätsmedizin Berlin will present in our CTGCT Science Talks webinar series. The talk is titled "Automation of ...